BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27667567)

  • 1. A novel regulatory relationship between RIPK4 and ELF3 in keratinocytes.
    Scholz GM; Sulaiman NS; Al Baiiaty S; Kwa MQ; Reynolds EC
    Cell Signal; 2016 Dec; 28(12):1916-1922. PubMed ID: 27667567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-interacting protein kinase 4 and interferon regulatory factor 6 function as a signaling axis to regulate keratinocyte differentiation.
    Kwa MQ; Huynh J; Aw J; Zhang L; Nguyen T; Reynolds EC; Sweet MJ; Hamilton JA; Scholz GM
    J Biol Chem; 2014 Nov; 289(45):31077-87. PubMed ID: 25246526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon Regulatory Factor 6 Promotes Keratinocyte Differentiation in Response to Porphyromonas gingivalis.
    Huynh J; Scholz GM; Aw J; Reynolds EC
    Infect Immun; 2017 May; 85(5):. PubMed ID: 28289145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RIPK4 activates an IRF6-mediated proinflammatory cytokine response in keratinocytes.
    Kwa MQ; Scholz GM; Reynolds EC
    Cytokine; 2016 Jul; 83():19-26. PubMed ID: 27014863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel RIPK4-IRF6 connection is required to prevent epithelial fusions characteristic for popliteal pterygium syndromes.
    De Groote P; Tran HT; Fransen M; Tanghe G; Urwyler C; De Craene B; Leurs K; Gilbert B; Van Imschoot G; De Rycke R; Guérin CJ; Holland P; Berx G; Vandenabeele P; Lippens S; Vleminckx K; Declercq W
    Cell Death Differ; 2015 Jun; 22(6):1012-24. PubMed ID: 25430793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-associated mutations in IRF6 and RIPK4 dysregulate their signalling functions.
    Kwa MQ; Huynh J; Reynolds EC; Hamilton JA; Scholz GM
    Cell Signal; 2015 Jul; 27(7):1509-16. PubMed ID: 25784454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RIPK4-IRF6 signalling axis safeguards epidermal differentiation and barrier function.
    Oberbeck N; Pham VC; Webster JD; Reja R; Huang CS; Zhang Y; Roose-Girma M; Warming S; Li Q; Birnberg A; Wong W; Sandoval W; Kőműves LG; Yu K; Dugger DL; Maltzman A; Newton K; Dixit VM
    Nature; 2019 Oct; 574(7777):249-253. PubMed ID: 31578523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon regulatory factor 6 promotes differentiation of the periderm by activating expression of Grainyhead-like 3.
    de la Garza G; Schleiffarth JR; Dunnwald M; Mankad A; Weirather JL; Bonde G; Butcher S; Mansour TA; Kousa YA; Fukazawa CF; Houston DW; Manak JR; Schutte BC; Wagner DS; Cornell RA
    J Invest Dermatol; 2013 Jan; 133(1):68-77. PubMed ID: 22931925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AP-1 and ets transcription factors regulate the expression of the human SPRR1A keratinocyte terminal differentiation marker.
    Sark MW; Fischer DF; de Meijer E; van de Putte P; Backendorf C
    J Biol Chem; 1998 Sep; 273(38):24683-92. PubMed ID: 9733767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RIPK4 activity in keratinocytes is controlled by the SCF
    Tanghe G; Urwyler-Rösselet C; De Groote P; Dejardin E; De Bock PJ; Gevaert K; Vandenabeele P; Declercq W
    Cell Mol Life Sci; 2018 Aug; 75(15):2827-2841. PubMed ID: 29435596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RIPK4 regulates cell-cell adhesion in epidermal development and homeostasis.
    Fortugno P; Monetta R; Belli M; Botti E; Angelucci F; Palmerini MG; Nottola SA; De Luca C; Ceccarini M; Salvatore M; Bianchi L; Macioce P; Teson M; Ricci F; ; Macchiarelli G; Didona B; Costanzo A; Castiglia D; Brancati F
    Hum Mol Genet; 2022 Aug; 31(15):2535-2547. PubMed ID: 35220430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratinocyte-Specific Ablation of RIPK4 Allows Epidermal Cornification but Impairs Skin Barrier Formation.
    Urwyler-Rösselet C; Tanghe G; Leurs K; Gilbert B; De Rycke R; De Bruyne M; Lippens S; Bartunkova S; De Groote P; Niessen C; Haftek M; Vandenabeele P; Declercq W
    J Invest Dermatol; 2018 Jun; 138(6):1268-1278. PubMed ID: 29317263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NOTCH-RIPK4-IRF6-ELOVL4 Axis Suppresses Squamous Cell Carcinoma.
    Yan Y; Gauthier MA; Malik A; Fotiadou I; Ostrovski M; Dervovic D; Ghadban L; Tsai R; Gish G; Loganathan SK; Schramek D
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profile of cornified envelope structural proteins and keratinocyte differentiation-regulating proteins during skin barrier repair.
    de Koning HD; van den Bogaard EH; Bergboer JG; Kamsteeg M; van Vlijmen-Willems IM; Hitomi K; Henry J; Simon M; Takashita N; Ishida-Yamamoto A; Schalkwijk J; Zeeuwen PL
    Br J Dermatol; 2012 Jun; 166(6):1245-54. PubMed ID: 22329734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR3 drives IRF6-dependent IL-23p19 expression and p19/EBI3 heterodimer formation in keratinocytes.
    Ramnath D; Tunny K; Hohenhaus DM; Pitts CM; Bergot AS; Hogarth PM; Hamilton JA; Kapetanovic R; Sturm RA; Scholz GM; Sweet MJ
    Immunol Cell Biol; 2015 Oct; 93(9):771-9. PubMed ID: 26303210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression.
    Longoni N; Sarti M; Albino D; Civenni G; Malek A; Ortelli E; Pinton S; Mello-Grand M; Ostano P; D'Ambrosio G; Sessa F; Garcia-Escudero R; Thalmann GN; Chiorino G; Catapano CV; Carbone GM
    Cancer Res; 2013 Jul; 73(14):4533-47. PubMed ID: 23687337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-specific ETS-1 (ESE1/ELF3) regulates apoptosis of intestinal epithelial cells in ulcerative colitis via accelerating NF-κB activation.
    Li L; Miao X; Ni R; Miao X; Wang L; Gu X; Yan L; Tang Q; Zhang D
    Immunol Res; 2015 Jun; 62(2):198-212. PubMed ID: 25926267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELF3 modulates type II collagen gene (COL2A1) transcription in chondrocytes by inhibiting SOX9-CBP/p300-driven histone acetyltransferase activity.
    Otero M; Peng H; Hachem KE; Culley KL; Wondimu EB; Quinn J; Asahara H; Tsuchimochi K; Hashimoto K; Goldring MB
    Connect Tissue Res; 2017 Jan; 58(1):15-26. PubMed ID: 27310669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of ELF3 facilitates cell growth and metastasis through PI3K/Akt and ERK signaling pathways in non-small cell lung cancer.
    Wang H; Yu Z; Huo S; Chen Z; Ou Z; Mai J; Ding S; Zhang J
    Int J Biochem Cell Biol; 2018 Jan; 94():98-106. PubMed ID: 29208568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.
    Yeung TL; Leung CS; Wong KK; Gutierrez-Hartmann A; Kwong J; Gershenson DM; Mok SC
    Oncotarget; 2017 Mar; 8(10):16951-16963. PubMed ID: 28199976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.